Drugs - Generic Companies' Annual Reports & Investor Relations Material

20 Companies

RX

Biosyent

BioSyent, a specialty pharmaceutical company listed on the TSX Venture Exchange, is focused on acquiring or in-licensing innovative pharmaceutical products that have been proven to be safe and effe...

Biosyent Annual Report 2023

Healthcare Drugs - Generic TSX-V 11-50

HZNP

Horizon Therapeutics Public Company

Dublin-based biotech firm, Horizon Therapeutics Public Limited Company, has made the development and commercialization of breakthrough treatments for rare, autoimmune, and severe inflammatory disea...

Horizon Therapeutics Public Company Annual Report 2021

Healthcare Drugs - Generic NASDAQ 501-1000

EVOK

Evoke Pharma Inc

Solana Beach-based specialty pharmaceutical company, Evoke Pharma, Inc., is dedicated to tackling gastroenterological disorders and diseases through the development and commercialization of innovat...

Evoke Pharma Inc Annual Report 2023

Healthcare Drugs - Generic NASDAQ 1-10

TTPH

Tetraphase Pharma Inc

Tetraphase is a clinical-stage biopharmaceutical company that specializes in creating antibiotics for severe and life-threatening bacterial infections. Using its innovative chemistry technology, th...

Tetraphase Pharma Inc Annual Report 2018

Healthcare Drugs - Generic NASDAQ 51-200

FLXN

Flexion Therapeutics Inc

Flexion Therapeutics is a company that specializes in creating pharmaceutical products to help patients with musculoskeletal conditions. Their focus is on developing anti-inflammatory and analgesic...

Flexion Therapeutics Inc Annual Report 2019

Healthcare Drugs - Generic NASDAQ 51-200